Biosimilars Policy

PUBLICATION TITLE AUTHORS DATE
FDLI’s Food and Drug Policy Forum “Biosimilar Nomenclature: Can We Achieve the Truth, the Whole Truth, & Nothing but the Truth?” Peter J. Pitts August 27, 2014
P&T “Biosimilars – Part 2: Potential Concerns and Challenges for P&T Committees” C. Lee Ventola June 2013
Swiss Medical Weekly “The advent of biosimilars: challenges and risks” Rüdiger Müller
Christoph Renner
Cem Gabay
Giuseppe Cassata
Andreas Lohri
Paul Hasler
July 1, 2014

 Biosimilars Development

PUBLICATION TITLE AUTHORS DATE
Breast Cancer Research & Treatment “Expert perspectives on biosimilar monoclonal antibodies in breast Cancer” J. Cortés
G. Curigliano
V. Diéras
February 10, 2014